Citations (122)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
Aki Shiozawa, Rebecca C. Thurston, Erin Cook, Hongbo Yang, Deanna D. King, Rita M. Kristy & Shayna Mancuso. (2023) Assessment of women’s treatment preferences for vasomotor symptoms due to menopause. Expert Review of Pharmacoeconomics & Outcomes Research 23:10, pages 1117-1128.
Read now
Read now
R. C. Thurston. (2023) Vasomotor symptoms and cardiovascular health: findings from the SWAN and the MsHeart/MsBrain studies. Climacteric 0:0, pages 1-6.
Read now
Read now
María del Carmen Carcelén-Fraile, Fidel Hita-Contreras, Antonio Martínez-Amat, Vânia Brandão Loureiro, Nuno Eduardo Marques de Loureiro, José Daniel Jiménez-García, Raquel Fábrega-Cuadros & Agustín Aibar-Almazán. (2023) Impact of Qigong exercises on the severity of the menopausal symptoms and health-related quality of life: A randomised controlled trial. European Journal of Sport Science 23:4, pages 656-664.
Read now
Read now
Gloria Richard-Davis, Andrea Singer, Deanna D King & Lisa Mattle. (2022) Understanding Attitudes, Beliefs, and Behaviors Surrounding Menopause Transition: Results from Three Surveys. Patient Related Outcome Measures 13, pages 273-286.
Read now
Read now
Julia Files & Juliana M Kling. (2020) Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review. Expert Opinion on Drug Delivery 17:4, pages 543-549.
Read now
Read now
F. Pimenta, M. M. Ramos, C. C. Silva, P. A. Costa, J. Maroco & I. Leal. (2020) Self-regulation model applied to menopause: a mixed-methods study. Climacteric 23:1, pages 84-92.
Read now
Read now
J. C. Prior. (2018) Progesterone for treatment of symptomatic menopausal women. Climacteric 21:4, pages 358-365.
Read now
Read now
R. C. Thurston. (2018) Vasomotor symptoms: natural history, physiology, and links with cardiovascular health. Climacteric 21:2, pages 96-100.
Read now
Read now
Xiangyan Ruan, Yamei Cui, Juan Du, Fengyu Jin & Alfred Otto Mueck. (2017) Prevalence of climacteric symptoms comparing perimenopausal and postmenopausal Chinese women. Journal of Psychosomatic Obstetrics & Gynecology 38:3, pages 161-169.
Read now
Read now
Sharon J. Parish & John A. Gillespie. (2017) The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms. Postgraduate Medicine 129:3, pages 340-351.
Read now
Read now
Risa Kagan, Steven R Goldstein, James H Pickar & Barry S Komm. (2016) Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene. Therapeutics and Clinical Risk Management 12, pages 549-562.
Read now
Read now
V. E. Radzinskii, I. V. Kuznetsova, Y. B. Uspenskaya, N. B. Repina, Y. K. Gusak, O. M. Zubova, D. I. Burchakov & A. A. Osmakova. (2016) Treatment of climacteric symptoms with an ammonium succinate-based dietary supplement: a randomized, double-blind, placebo-controlled trial. Gynecological Endocrinology 32:sup2, pages 64-68.
Read now
Read now
C. Gerlinger, K. Gude, T. Schmelter, M. Schaefers & J. Endrikat. (2015) 0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes. Climacteric 18:4, pages 512-517.
Read now
Read now
E. S. Mitchell & N. F. Woods. (2015) Hot flush severity during the menopausal transition and early postmenopause: beyond hormones. Climacteric 18:4, pages 536-544.
Read now
Read now
Andrea R Genazzani, Barry S Komm & James H Pickar. (2015) Emerging hormonal treatments for menopausal symptoms. Expert Opinion on Emerging Drugs 20:1, pages 31-46.
Read now
Read now
Camil Castelo-Branco & Iris Soveral. (2014) Clinical efficacy of estradiol transdermal system in the treatment of hot flashes in postmenopausal women. Research and Reports in Transdermal Drug Delivery 3, pages 1-8.
Read now
Read now
O. K. Duffy, L. Iversen & P. C. Hannaford. (2013) Factors associated with reporting classic menopausal symptoms differ. Climacteric 16:2, pages 240-251.
Read now
Read now
M. Andrikoula, D. Baker, J. Nesic, L. M. Liao, T. Duka & G. M. Prelevic. (2011) The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women. Climacteric 14:5, pages 544-550.
Read now
Read now
Pauliina Tuomikoski, Olavi Ylikorkala & Tomi S. Mikkola. (2011) Menopausal hot flushes and vascular health. Annals of Medicine 43:4, pages 283-291.
Read now
Read now
Wen Shen & Vered Stearns. (2009) Treatment strategies for hot flushes. Expert Opinion on Pharmacotherapy 10:7, pages 1133-1144.
Read now
Read now
M. Andrikoula & G. Prelevic. (2009) Menopausal hot flushes revisited. Climacteric 12:1, pages 3-15.
Read now
Read now
Maria Andrikoula, Paul Hardiman & Gordana Prelevic. (2009) Menopausal hot flush: Is it only a nuisance or also a marker of cardiovascular disease risk?. Gynecological Endocrinology 25:7, pages 450-454.
Read now
Read now
MargaretL. Stubbs, SusanM. Cohen & Feridey Carr. (2008) Menopausal Women's Perceived Causes of Hot Flash. Health Care for Women International 29:7, pages 755-765.
Read now
Read now
Articles from other publishers (99)
Laura Cucinella, Lara Tiranini & Rossella E. Nappi. (2023) Impact of climate and environmental change on the menopause. Maturitas 178, pages 107825.
Crossref
Crossref
Barbara DePree, Aki Shiozawa, Deanna King, Arianne Schild, Mo ZhouHongbo YangShayna Mancuso. (2023) Association of menopausal vasomotor symptom severity with sleep and work impairments: a US survey. Menopause 30:9, pages 887-897.
Crossref
Crossref
Carolyn J. Gibson, Aki Shiozawa, Andrew J. Epstein, Wei Han & Shayna Mancuso. (2023) Association between vasomotor symptom frequency and weight gain in the Study of Women's Health Across the Nation. Menopause 30:7, pages 709-716.
Crossref
Crossref
Sarah Carter, Nicole T. Vargas, Richard de Dear, Kirsten I. Black & Ollie Jay. (2023) A comparison of air temperature thresholds for warm thermal discomfort between pre- and post-menopausal women. Building and Environment 239, pages 110421.
Crossref
Crossref
Jerilynn C. Prior, Andrea Cameron, Michelle Fung, Christine L. Hitchcock, Patricia Janssen, Terry Lee & Joel Singer. (2023) Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial. Scientific Reports 13:1.
Crossref
Crossref
Andrea LaCroix & Kristine Ensrud. (2023) The flash dance of midlife: the Skylight 1 trial. Nature Medicine.
Crossref
Crossref
Stephanie S. Faubion, Taryn Smith, Jacqueline Thielen, Juliana M. Kling, Chrisandra L. Shufelt, Kristin Mara, Felicity Enders & Ekta Kapoor. (2023) Association of Migraine and Vasomotor Symptoms. Mayo Clinic Proceedings 98:5, pages 701-712.
Crossref
Crossref
James A. Simon, Richard A. Anderson, Elizabeth Ballantyne, James Bolognese, Cecilia Caetano, Hadine Joffe, Mary Kerr, Nick Panay, Christian Seitz, Susan Seymore, Mike Trower, Lineke Zuurman & Steve Pawsey. (2023) Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1). Menopause 30:3, pages 239-246.
Crossref
Crossref
Rebecca C. Thurston, Minjie WuYue-Fang ChangHoward J. Aizenstein, Carol A. Derby, Emma A. Barinas-Mitchell & Pauline Maki. (2023) Menopausal Vasomotor Symptoms and White Matter Hyperintensities in Midlife Women. Neurology 100:2.
Crossref
Crossref
Natalie V. Scime, Alison K. Shea, Peter D. Faris & Erin A. Brennand. (2022) Impact of lifetime lactation on the risk and duration of frequent vasomotor symptoms: A longitudinal dose–response analysis. BJOG: An International Journal of Obstetrics & Gynaecology 130:1, pages 89-98.
Crossref
Crossref
Barbara DePree, Katherine Houghton, Aki Shiozawa, Elizabeth Esterberg, Deanna D. King, Janet Kim & Shayna Mancuso. (2023) Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records. Menopause 30:1, pages 70-79.
Crossref
Crossref
Seyedeh Hajar Sharami, Roya Faraji Darkhaneh, Nasrin Ghanami Gashti, Mandana Mansour-Ghanaei & Sedighe Bab Eghbal. (2022) The association between reproductive history and menopausal symptoms: an evidence from the cross-sectional survey. BMC Women's Health 22:1.
Crossref
Crossref
Kerstin Rödström, Lilian Weman, Valter Sundh & Cecilia Björkelund. (2022) Perception of higher frequency of daily hot flashes in 50-year-old women today: a study of trends over time during 48 years in the Population Study of Women in Gothenburg, Sweden. Menopause 29:10, pages 1124-1129.
Crossref
Crossref
Petra Stute, Antonio Cano, Rebecca C. Thurston, Mark Small, Lauren Lee, Megan Scott, Emad Siddiqui & Neil M. Schultz. (2022) Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States. Maturitas 164, pages 38-45.
Crossref
Crossref
Nicholas J. Andersen, Jessica L. Parker, Susanne Pettigrew & Diana Bitner. (2022) Validation of the Menopause Transition Scale (MTS). Menopause 29:7, pages 868-876.
Crossref
Crossref
Kristen M. Culbert, Katharine N. Thakkar & Kelly L. Klump. (2022) Risk for midlife psychosis in women: critical gaps and opportunities in exploring perimenopause and ovarian hormones as mechanisms of risk. Psychological Medicine 52:9, pages 1612-1620.
Crossref
Crossref
Rossella E Nappi, Peter Chedraui, Irene Lambrinoudaki & Tommaso Simoncini. (2022) Menopause: a cardiometabolic transition. The Lancet Diabetes & Endocrinology 10:6, pages 442-456.
Crossref
Crossref
Emma Macías-Cortés. (2021) Menopause is more than Hot Flashes: What is Missing in Homeopathic Research? A Narrative Review. Homeopathy 111:02, pages 079-096.
Crossref
Crossref
Gabriela Leite, Gillian M. Barlow, Gonzalo Parodi, Maya L. Pimentel, Christine Chang, Ava Hosseini, Jiajing Wang, Mark Pimentel & Ruchi Mathur. (2022) Duodenal microbiome changes in postmenopausal women: effects of hormone therapy and implications for cardiovascular risk. Menopause 29:3, pages 264-275.
Crossref
Crossref
Jing Xiong, Sarah Carter, Ollie Jay, Edward Arens, Hui Zhang, Max Deuble & Richard de Dear. (2021) A sex/age anomaly in thermal comfort observed in an office worker field study: A menopausal effect?. Indoor Air 32:1.
Crossref
Crossref
Maija Lipasti, Jaana Jalava-Broman, Lauri Sillanmäki, Juha Mäkinen & Päivi Rautava. (2021) Climacteric symptoms more severe in 2010 than in 2000 – experience of Finnish women aged 52–56 years not now or previously on menopausal hormone therapy. Maturitas 154, pages 20-24.
Crossref
Crossref
Elizabeth Marie King, Jerilynn C Prior, Neora Pick, Julie van Schalkwyk, Mary Kestler, Stacey Tkachuk, Mona Loutfy & Melanie C M Murray. (2021) Menopausal hormone therapy for women living with HIV. The Lancet HIV 8:9, pages e591-e598.
Crossref
Crossref
Rossella E. Nappi, Robin Kroll, Emad Siddiqui, Boyka Stoykova, Carol Rea, Eric Gemmen & Neil M. Schultz. (2021) Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden. Menopause 28:8, pages 875-882.
Crossref
Crossref
Monika Gorczyca. (2021) Vasomotorische Beschwerden in der MenopauseVasomotor Symptoms During Menopause. Journal für Gynäkologische Endokrinologie/Österreich 31:2, pages 79-81.
Crossref
Crossref
Rebecca C. Thurston, Helen E. Aslanidou Vlachos, Carol A. Derby, Elizabeth A. Jackson, Maria Mori Brooks, Karen A. Matthews, Sioban Harlow, Hadine Joffe & Samar R. El Khoudary. (2021) Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN. Journal of the American Heart Association 10:3.
Crossref
Crossref
Megan Arnot, Emily H. Emmott & Ruth Mace. (2021) The relationship between social support, stressful events, and menopause symptoms. PLOS ONE 16:1, pages e0245444.
Crossref
Crossref
Dongshan Zhu, Hsin-Fang Chung, Annette J. Dobson, Nirmala Pandeya, Debra J. Anderson, Diana Kuh, Rebecca Hardy, Eric J. Brunner, Nancy E. Avis, Ellen B. Gold, Samar R. El Khoudary, Sybil L. Crawford & Gita D. Mishra. (2020) Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. American Journal of Obstetrics and Gynecology 223:6, pages 898.e1-898.e16.
Crossref
Crossref
Ruiyi Tang, Min Luo, Jiayi Li, Yajing Peng, Yuchen Wang, Bing Liu, Gaifen Liu, Yaping Wang, Shouqing Lin & Rong Chen. (2020) Relationships Between Vasomotor Symptoms and Mood in Midlife Urban Chinese Women: Observations in a Prospective Study. The Journal of Clinical Endocrinology & Metabolism 105:11, pages 3437-3448.
Crossref
Crossref
Ginger D. Constantine, James A. Simon, Andrew M. Kaunitz, James H. Pickar, Dennis A. Revicki, Shelli GrahamBrian BernickSebastian Mirkin. (2020) TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial. Menopause 27:11, pages 1236-1241.
Crossref
Crossref
Alana M C Brown & Nicole J Gervais. (2020) Role of Ovarian Hormones in the Modulation of Sleep in Females Across the Adult Lifespan. Endocrinology 161:9.
Crossref
Crossref
Siobán D. Harlow, Michael R. Elliott, Irina Bondarenko, Rebecca C. Thurston & Elizabeth A. Jackson. (2020) Monthly variation of hot flashes, night sweats, and trouble sleeping: effect of season and proximity to the final menstrual period (FMP) in the SWAN Menstrual Calendar substudy. Menopause 27:1, pages 5-13.
Crossref
Crossref
Jerilynn C. Prior. (2020) Balanced actions of estradiol and progesterone—A new paradigm of women’s reproductive health. Drug Discovery Today: Disease Models 32, pages 27-29.
Crossref
Crossref
Yubo Fan, Ruiyi Tang, Jerilynn C. Prior & Rong Chen. (2020) Paradigm shift in pathophysiology of vasomotor symptoms: Effects of estradiol withdrawal and progesterone therapy. Drug Discovery Today: Disease Models 32, pages 59-69.
Crossref
Crossref
Marie K. Christakis, Donna M. Strobino & Wen Shen. (2019) A critical appraisal of vasomotor symptom assessment tools used in clinical trials evaluating hormone therapy compared to placebo. Menopause 26:11, pages 1334-1341.
Crossref
Crossref
Viktor E. Radzinsky, Yulia Uspenskaya, Lee P. Shulman & Irina V. Kuznetsova. (2019) Succinate-Based Dietary Supplement for Menopausal Symptoms: A Pooled Analysis of Two Identical Randomized, Double-Blind, Placebo-Controlled Clinical Trials. Obstetrics and Gynecology International 2019, pages 1-9.
Crossref
Crossref
Jan L. Shifren, Rebekah Zincavage, Ellen L. Cho, Ashley Magnavita, David J. Portman, Michael L. Krychman, James A. Simon, Sheryl A. KingsbergRaymond C. Rosen. (2019) Women's experience of vulvovaginal symptoms associated with menopause. Menopause 26:4, pages 341-349.
Crossref
Crossref
Nancy E. Avis, Sybil L. Crawford & Robin Green. (2018) Vasomotor Symptoms Across the Menopause Transition. Obstetrics and Gynecology Clinics of North America 45:4, pages 629-640.
Crossref
Crossref
Clarisa R. Gracia & Ellen W. Freeman. (2018) Onset of the Menopause Transition. Obstetrics and Gynecology Clinics of North America 45:4, pages 585-597.
Crossref
Crossref
Rebecca C. Thurston, Yuefang Chang, Emma Barinas-Mitchell, J. Richard Jennings, Roland von KänelDoug P. Landsittel & Karen A. Matthews. (2018) Physiologically assessed hot flashes and endothelial function among midlife women. Menopause 25:11, pages 1354-1361.
Crossref
Crossref
Evelyn Wong, George Tomlinson, Marsha Pinto, Claudie Berger, Angela Cheung & Jerilynn Prior. (2018) Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos). International Journal of Environmental Research and Public Health 15:6, pages 1079.
Crossref
Crossref
Wing Yu Tang, Dale Grothe, Allison Keshishian, Diana Morgenstern & Seema Haider. (2018) Pharmacoeconomic and associated cost savings among women who were prescribed systemic conjugated estrogens therapy compared with those without menopausal therapy. Menopause 25:5, pages 493-499.
Crossref
Crossref
Jeffrey Frederico Lui-Filho, Adriana Orcesi Pedro, Luiz Francisco Baccaro & Lucia Costa-Paiva. (2018) Risk factors associated with intensity of climacteric symptoms in Brazilian middle-aged women: a population-based household survey. Menopause 25:4, pages 415-422.
Crossref
Crossref
Mohammed D. Saleem. (2018) Revisiting Rosacea Criteria. Dermatologic Clinics 36:2, pages 161-165.
Crossref
Crossref
Mohammed D. Saleem & Jonathan K. Wilkin. (2018) Evaluating and Optimizing the Diagnosis of Erythematotelangiectatic Rosacea. Dermatologic Clinics 36:2, pages 127-134.
Crossref
Crossref
Bridget Martell, Dana B. DiBenedetti, Herman Weiss, Xiaolei Zhou, Maria Reynolds, Vincenzo Berghella & Sonia S. Hassan. (2017) Screening and treatment for short cervical length in pregnancy: a physician survey in the United States. Archives of Gynecology and Obstetrics 297:3, pages 601-611.
Crossref
Crossref
Rebecca C. Thurston, Yuefang Chang, Emma Barinas-Mitchell, J. Richard Jennings, Roland von KänelDoug P. Landsittel & Karen A. Matthews. (2017) Physiologically assessed hot flashes and endothelial function among midlife women. Menopause 24:8, pages 886-893.
Crossref
Crossref
Ellen B. Gold, Sybil L. Crawford, Janie F. Shelton, Ping G. Tepper, Carolyn J. Crandall, Gail A. Greendale, Karen A. Matthews, Rebecca C. Thurston & Nancy E. Avis. (2017) Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN). Menopause 24:1, pages 9-26.
Crossref
Crossref
Pippa Anderson, Caroline O’Leary, Margaret Moffat & Xuemei Luo. (2016) Hormone replacement therapy use in UK general practice: Duration, discontinuation and women’s experience. Post Reproductive Health 22:4, pages 155-164.
Crossref
Crossref
Rebecca C. ThurstonYuefang ChangEmma Barinas-MitchellJ. Richard JenningsDoug P. LandsittelNanette SantoroRoland von KänelKaren A. Matthews. (2016) Menopausal Hot Flashes and Carotid Intima Media Thickness Among Midlife Women. Stroke 47:12, pages 2910-2915.
Crossref
Crossref
William I. Fisher & Rebecca C. Thurston. (2016) Measuring hot flash phenomenonology using ambulatory prospective digital diaries. Menopause 23:11, pages 1222-1227.
Crossref
Crossref
David F. ArcherEllen W. FreemanBarry S. KommKelly A. RyanChing-Ray YuSebastian MirkinJoAnn V. Pinkerton. (2016) Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials. Journal of Women's Health 25:11, pages 1102-1111.
Crossref
Crossref
D Wei, Y Chen, C Wu, Q Wu, L Yao, Q Wang, XQ Wang & KH Yang. (2016) Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis. BJOG: An International Journal of Obstetrics & Gynaecology 123:11, pages 1735-1743.
Crossref
Crossref
Megumi Yokota, Kazuya Makita, Akira Hirasawa, Takashi Iwata & Daisuke Aoki. (2016) Symptoms and effects of physical factors in Japanese middle-aged women. Menopause 23:9, pages 974-983.
Crossref
Crossref
Charles H. Tegeler, Catherine L. Tegeler, Jared F. Cook, Sung W. Lee & Nicholas M. Pajewski. (2015) Reduction in menopause-related symptoms associated with use of a noninvasive neurotechnology for autocalibration of neural oscillations. Menopause 22:6, pages 650-655.
Crossref
Crossref
Bette Caan, Andrea Z. LaCroix, Hadine Joffe, Katherine A. Guthrie, Joseph C. Larson, Janet S. Carpenter, Lee S. Cohen, Ellen W. Freeman, JoAnn E. Manson, Katherine Newton, Susan Reed, Kathy Rexrode, Jan Shifren, Barbara Sternfeld & Kris Ensrud. (2015) Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes. Menopause 22:6, pages 607-615.
Crossref
Crossref
Erika Borkoles, Nick Reynolds, David R. Thompson, Chantal F. Ski, Lily Stojanovska & Remco C.J. Polman. (2015) The role of depressive symptomatology in peri- and post-menopause. Maturitas 81:2, pages 306-310.
Crossref
Crossref
Kathleen LangIvy M. AlexanderJames SimonMatthew SussmanIris LinJoseph MenzinMark FriedmanDavid DutwinAndrew G. Bushmakin, Maia Thrift-PerryCorrado AltomareMing-Ann Hsu. (2015) The Impact of Multimorbidity on Quality of Life Among Midlife Women: Findings from a U.S. Nationally Representative Survey. Journal of Women's Health 24:5, pages 374-383.
Crossref
Crossref
Stephanie S. Faubion, Richa Sood, Jacqueline M. Thielen & Lynne T. Shuster. (2015) Caffeine and menopausal symptoms. Menopause 22:2, pages 155-158.
Crossref
Crossref
JoAnn V. Pinkerton, Hadine Joffe, Kazem Kazempour, Hana Mekonnen, Sailaja Bhaskar & Joel Lippman. (2015) Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause. Menopause 22:1, pages 50-58.
Crossref
Crossref
Rebecca C. Thurston, Linda J. Ewing, Carissa A. Low, Aimee J. Christie & Michele D. Levine. (2015) Behavioral weight loss for the management of menopausal hot flashes. Menopause 22:1, pages 59-65.
Crossref
Crossref
Gabriella M. van Dijk, Maryam Kavousi, Jenna Troup & Oscar H. Franco. (2015) Health issues for menopausal women: The top 11 conditions have common solutions. Maturitas 80:1, pages 24-30.
Crossref
Crossref
Nancy Fugate Woods & Ellen Sullivan Mitchell. 2015. Skin, Mucosa and Menopause. Skin, Mucosa and Menopause
433
452
.
Zhishun Liu, Yang Wang, Huanfang Xu, Jiani Wu, Liyun He, John Yi Jiang, Shiyan Yan, Ruosang Du & Baoyan Liu. (2014) Efficacy of electroacupuncture for symptoms of menopausal transition: study protocol for a randomized controlled trial. Trials 15:1.
Crossref
Crossref
David J. Portman, Andrew M. Kaunitz, Kazem Kazempour, Hana Mekonnen, Sailaja Bhaskar & Joel Lippman. (2014) Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause. Menopause 21:10, pages 1082-1090.
Crossref
Crossref
Ellen W. Freeman, Mary D. Sammel & Richard J. Sanders. (2014) Risk of long-term hot flashes after natural menopause. Menopause 21:9, pages 924-932.
Crossref
Crossref
Pragya Gartoulla & Myo Mint Han. (2014) Red clover extract for alleviating hot flushes in postmenopausal women: A meta-analysis. Maturitas 79:1, pages 58-64.
Crossref
Crossref
Nancy E. Avis, Claudine Legault, Gregory Russell, Kathryn Weaver & Suzanne C. Danhauer. (2014) Pilot study of integral yoga for menopausal hot flashes. Menopause 21:8, pages 846-854.
Crossref
Crossref
Suprawita Saensak, Teraporn Vutyavanich, Woraluk Somboonporn & Manit Srisurapanont. (2014) Relaxation for perimenopausal and postmenopausal symptoms. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Carolyn L Smith, Richard J Santen, Barry Komm & Sebastian Mirkin. (2014) Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes. Breast Cancer Research 16:3.
Crossref
Crossref
Sarah E. McBane, Laura M. Borgelt, Kylie N. Barnes, Sarah M. Westberg, Nicole M. Lodise & Martha Stassinos. (2014) Use of Compounded Bioidentical Hormone Therapy in Menopausal Women: An Opinion Statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:4, pages 410-423.
Crossref
Crossref
Susan D. Reed, Katherine A. Guthrie, Katherine M. Newton, Garnet L. Anderson, Cathryn Booth-LaForce, Bette Caan, Janet S. Carpenter, Lee S. Cohen, Andrea L. Dunn, Kristine E. Ensrud, Ellen W. Freeman, Julie R. Hunt, Hadine Joffe, Joseph C. Larson, Lee A. Learman, Robin Rothenberg, Rebecca A. Seguin, Karen J. Sherman, Barbara S. Sternfeld & Andrea Z. LaCroix. (2014) Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements. American Journal of Obstetrics and Gynecology 210:3, pages 244.e1-244.e11.
Crossref
Crossref
James A. Simon, Rossella E. Nappi, Sheryl A. Kingsberg, Ricardo Maamari & Vivien Brown. (2014) Clarifying Vaginal Atrophy’s Impact on Sex and Relationships (CLOSER) survey. Menopause 21:2, pages 137-142.
Crossref
Crossref
Sebastian Mirkin, Kelly A. Ryan, Arthi B. Chandran & Barry S. Komm. (2014) Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms. Maturitas 77:1, pages 24-31.
Crossref
Crossref
Sebastian Mirkin & Barry S. Komm. (2013) Tissue-selective estrogen complexes for postmenopausal women. Maturitas 76:3, pages 213-220.
Crossref
Crossref
James A. Simon, David J. Portman, Andrew M. Kaunitz, Hana Mekonnen, Kazem Kazempour, Sailaja Bhaskar & Joel Lippman. (2013) Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms. Menopause 20:10, pages 1027-1035.
Crossref
Crossref
Nathan G. Kase. 2013. Altchek's Diagnosis and Management of Ovarian Disorders. Altchek's Diagnosis and Management of Ovarian Disorders
287
324
.
M. Cristina Castelli, Sailaja Bhaskar & Joel Lippman. (2013) Pharmacokinetic Properties of Once-Daily Oral Low-Dose Mesylate Salt of Paroxetine (LDMP 7.5 mg) Following Single and Multiple Doses in Healthy Postmenopausal Women. Clinical Therapeutics 35:6, pages 862-869.
Crossref
Crossref
Barbara Sternfeld, Andrea LaCroix, Bette J. Caan, Andrea L. Dunn, Katherine M. Newton, Susan D. Reed, Katherine A. Guthrie, Cathryn Booth-LaForce, Karen J. Sherman, Lee Cohen, Marlene P. Freeman, Janet S. Carpenter, Julie R. Hunt, Melanie Roberts & Kristine E. Ensrud. (2013) Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: The MsFLASH experience. Contemporary Clinical Trials 35:1, pages 25-34.
Crossref
Crossref
O. Baser, L. Xie & J. Du. (2013) Application of Probabilistic Linkage: Compare Health Care Costs among Menopausal Women with Different Symptoms by Linking Women’s Registry & Claims Data. International Journal of Statistics in Medical Research 2:1, pages 34-39.
Crossref
Crossref
Andrea Z. LaCroix, Ellen W. Freeman, Joseph Larson, Janet S. Carpenter, Hadine Joffe, Susan D. Reed, Katherine M. Newton, Rebecca A. Seguin, Barbara Sternfeld, Lee Cohen & Kristine E. Ensrud. (2012) Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: A randomized controlled trial. Maturitas 73:4, pages 361-368.
Crossref
Crossref
Josephine M. Norquist, Cynthia Girman, Sheri Fehnel, Carla DeMuro-Mercon & Nancy Santanello. (2011) Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration. Quality of Life Research 21:6, pages 1013-1020.
Crossref
Crossref
Olga B. A. van den Akker. 2012. Reproductive Health Psychology. Reproductive Health Psychology
317
332
.
Rebecca C. Thurston, Nanette Santoro & Karen A. Matthews. (2011) Adiposity and Hot Flashes in Midlife Women: A Modifying Role of Age. The Journal of Clinical Endocrinology & Metabolism 96:10, pages E1588-E1595.
Crossref
Crossref
Nancy Fugate Woods & Ellen Sullivan Mitchell. (2011) Symptom interference with work and relationships during the menopausal transition and early postmenopause. Menopause 18:6, pages 654-661.
Crossref
Crossref
Dana Britt DiBenedetti, Dat Nguyen, Laurie Zografos, Ryan Ziemiecki & Xiaolei Zhou. (2010) Prevalence, Incidence, and Treatments of Dupuytren's Disease in the United States: Results from a Population-Based Study. HAND 6:2, pages 149-158.
Crossref
Crossref
Ellen W. Freeman, Mary D. Sammel, Hui Lin, Ziyue Liu & Clarisa R. Gracia. (2011) Duration of Menopausal Hot Flushes and Associated Risk Factors. Obstetrics & Gynecology 117:5, pages 1095-1104.
Crossref
Crossref
Dana Britt DiBenedetti, Dat Nguyen, Laurie Zografos, Ryan Ziemiecki & Xiaolei Zhou. (2011) A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States. Advances in Urology 2011, pages 1-9.
Crossref
Crossref
Ayelet Ziv-GalJodi A. Flaws. (2010) Factors That May Influence the Experience of Hot Flushes by Healthy Middle-Aged Women. Journal of Women's Health 19:10, pages 1905-1914.
Crossref
Crossref
Kristen B. Van Dole, Rachel E. Williams, Rebekkah S. Brown, Bradley Gaynes, Robert DeVellis & Michele Jonsson Funk. (2010) Longitudinal association of vasomotor symptoms and psychosocial outcomes among postmenopausal women in the United States. Menopause 17:5, pages 917-923.
Crossref
Crossref
Suprawita Saensak, Teraporn Vutyavanich, Woraluk Somboonporn & Manit Srisurapanont. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Joan Tan Garcia, Florante Gonzaga, Delfin Tan, Toon Yaa Ng, Pau Ling Oei & Cathryn W.B. Chan. (2010) Use of a multibotanical (Nutrafem) for the relief of menopausal vasomotor symptoms. Menopause 17:2, pages 303-308.
Crossref
Crossref
H. Rozenbaum. (2010) Ménopause. EMC - Endocrinologie - Nutrition 7:4, pages 1-19.
Crossref
Crossref
Tonita Wroolie & Megan Holcomb. 2010. A Public Health Perspective of Women’s Mental Health. A Public Health Perspective of Women’s Mental Health
143
164
.
Johan Svartberg, Denise von Mühlen, Donna Kritz-Silverstein & Elizabeth Barrett-Connor. (2009) Vasomotor symptoms and mortality. Menopause 16:5, pages 888-891.
Crossref
Crossref
Leslie Spangler, Susan D. Reed, Larissa Nekhyludov, Louis C. Grothaus, Andrea Z. LaCroix & Katherine M. Newton. (2009) Provider attributes associated with hormone therapy prescribing frequency. Menopause 16:4, pages 810-816.
Crossref
Crossref
Ann M. Berger, Heather A. Treat Marunda & Sangeeta Agrawal. (2009) Influence of Menopausal Status on Sleep and Hot Flashes Throughout Breast Cancer Adjuvant Chemotherapy. Journal of Obstetric, Gynecologic & Neonatal Nursing 38:3, pages 353-366.
Crossref
Crossref
Rachel E. Williams, Kristen B. Levine, Linda Kalilani, Jacqueline Lewis & Richard V. Clark. (2009) Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas 62:2, pages 153-159.
Crossref
Crossref
Youngwhee Lee & Hwasoon Kim. (2008) Relationships between menopausal symptoms, depression, and exercise in middle-aged women: A cross-sectional survey. International Journal of Nursing Studies 45:12, pages 1816-1822.
Crossref
Crossref
Audrey ParkeKathy Abernethy. (2008) Hormone replacement therapy: risks and benefits. Nurse Prescribing 6:10, pages 433-439.
Crossref
Crossref